Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
2,000.00    96.50 (5.07%)
Bid:
2,284.00
Ask:
1,523.00
Spread: -761.00 (-33.319%)
Market Cap: £76.31b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

Japan to review GSK's Blenrep drug application
17 Sep 2024

Japan to review GSK's Blenrep drug application

(Sharecast News) - Japan's health ministry has accepted for review a new drug application (NDA) for GSK's Blenrep blood cancer treatment, marking the ...

London close: Stocks finish firmer in subdued trading
13 Sep 2024

London close: Stocks finish firmer in subdued trading

(Sharecast News) - London stocks closed in positive territory on Friday, bolstered by hopes of an interest rate cut in the United States, although the...

GSK myeloma treatment given breakthrough therapy designation in China
13 Sep 2024

GSK myeloma treatment given breakthrough therapy designation in China

(Alliance News) - GSK PLC on Friday announced that it has been granted breakthrough therapy designation in China for Blenrep, a treatment for relapsed...

GSK to speed up development of blood cancer treatment in China
13 Sep 2024

GSK to speed up development of blood cancer treatment in China

(Sharecast News) - China's health authority has granted GSK's Blenrep blood cancer treatment with a so-called 'Breakthrough Therapy Designation' (BTD)...

GSK reports positive results from mRNA flu vaccine trial
12 Sep 2024

GSK reports positive results from mRNA flu vaccine trial

(Sharecast News) - GSK announced promising results from its phase two clinical trial for an mRNA-based seasonal flu vaccine on Thursday.

TOP NEWS: GSK welcomes positive findings on possible flu treatment
12 Sep 2024

TOP NEWS: GSK welcomes positive findings on possible flu treatment

(Alliance News) - GSK PLC on Thursday hailed a "significant advancement" as it reported positive findings from a trial on a possible flu vaccine.

LONDON BRIEFING: Trainline lifts guidance; Kier Group earnings climb
12 Sep 2024

LONDON BRIEFING: Trainline lifts guidance; Kier Group earnings climb

(Alliance News) - Stocks prices in London are called to open sharply higher on Thursday, after a rip-roaring climb for US tech shares overnight helped...

LONDON MARKET MIDDAY: FTSE 100 in uninspiring gain before US data
11 Sep 2024

LONDON MARKET MIDDAY: FTSE 100 in uninspiring gain before US data

(Alliance News) - London's FTSE 100 underperformed European peers, but headed into Wednesday afternoon just about in the green as a US inflation readi...